The Real Mechanisms of Emodin Treating Lung Cancer Based on System Pharmacology

Hai-hong Lin
{"title":"The Real Mechanisms of Emodin Treating Lung Cancer Based on System Pharmacology","authors":"Hai-hong Lin","doi":"10.14744/ejmo.2023.35261","DOIUrl":null,"url":null,"abstract":"and their related molecules have little benefit in improving survival, prognosis, recurrence and metastasis despite tumor size shrinkage. Compared with these routine treatment methods, the traditional Chinese medicine (TCM) cancer therapy based on TCM theory, in which the cancer initiation is regarded as disorder of human body system, focuses on the events impacting the gene rather than the gene itself. In fact, it is necessary but not sufficient for cancer initiation and progression to activate OCG or inactivate TSG, which exhibit oncogene or tumor-suppressor property depending on the biological context. In TCM theory, lung and large intestine are external-internal relations of each other, which are physiologically related and pathologically affected each other. Hence, the use of a classical laxative medicine rhubarb for lung cancer treatment is in line with TCM theory. Emodin as the major component of rhubarb represents the multi-targeting therapeutic mechanisms of TCM in multiple disease treatment including anti-cancer. There are some reviews on microscopic and inner mechanisms of emodin in cancer treatment, our previous study confirmed lung cancer-preventing effect of lung cancer. Here, we summarize the real mechanisms of emodin treating lung cancer based on system pharmacology, mainly focusing on the resolution of intrinsic pathological inducers, which will provide a solid foundation to understand cancer pathogenesis and formulate cancer therapy.","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":"15 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eurasian Journal of Medicine and Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/ejmo.2023.35261","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

and their related molecules have little benefit in improving survival, prognosis, recurrence and metastasis despite tumor size shrinkage. Compared with these routine treatment methods, the traditional Chinese medicine (TCM) cancer therapy based on TCM theory, in which the cancer initiation is regarded as disorder of human body system, focuses on the events impacting the gene rather than the gene itself. In fact, it is necessary but not sufficient for cancer initiation and progression to activate OCG or inactivate TSG, which exhibit oncogene or tumor-suppressor property depending on the biological context. In TCM theory, lung and large intestine are external-internal relations of each other, which are physiologically related and pathologically affected each other. Hence, the use of a classical laxative medicine rhubarb for lung cancer treatment is in line with TCM theory. Emodin as the major component of rhubarb represents the multi-targeting therapeutic mechanisms of TCM in multiple disease treatment including anti-cancer. There are some reviews on microscopic and inner mechanisms of emodin in cancer treatment, our previous study confirmed lung cancer-preventing effect of lung cancer. Here, we summarize the real mechanisms of emodin treating lung cancer based on system pharmacology, mainly focusing on the resolution of intrinsic pathological inducers, which will provide a solid foundation to understand cancer pathogenesis and formulate cancer therapy.
基于系统药理学的大黄素治疗肺癌的真实机制
尽管肿瘤体积缩小,但其相关分子在改善生存、预后、复发和转移方面收效甚微。与这些常规治疗方法相比,以中医理论为基础的中医癌症治疗,将癌症的发生视为人体系统的紊乱,关注的是影响基因的事件而不是基因本身。事实上,激活OCG或灭活TSG对于癌症的发生和发展是必要的,但不是充分的,TSG根据生物学背景表现出癌基因或肿瘤抑制特性。在中医理论中,肺与大肠互为内外关系,在生理上相互联系,在病理上相互影响。因此,使用经典泻药大黄治疗肺癌是符合中医理论的。大黄素作为大黄的主要成分,体现了中医药治疗包括抗癌在内的多种疾病的多靶点治疗机制。对大黄素在肿瘤治疗中的微观机制和内部机制进行了综述,我们的前期研究证实了大黄素对肺癌的预防作用。本文以系统药理学为基础,总结大黄素治疗肺癌的真实机制,重点探讨其内在病理诱导剂的解析,为了解肿瘤发病机制和制定肿瘤治疗方案提供坚实的基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.60
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信